Arnas Tamasauskas

Arnas Tamasauskas

Auto-generated profile, based on publicly available information

Arnas Tamasauskas

University of Liverpool, Foundation Building, 765 Brownlow Hill, Liverpool L69 7ZX, United Kingdom

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2024 in The Journal of Pain
Verified
Journal Article
Open access
ATArnas Tamasauskas
Arnas Tamasauskas
BSBarbara Silva-Passadouro
Barbara Silva-Passadouro
NFNicholas Fallon
Nicholas Fallon
BFBernhard Frank
Bernhard Frank
SLSvajune Laurinaviciute
Svajune Laurinaviciute
AMAndrew G. Marshall
Andrew G. Marshall
Central post stroke pain (CPSP) is a neuropathic pain condition prevalent in 8% to 35% of stroke patients. This systematic review and meta-analysis aimed to provide insight in the effectiveness of available pharmacological, physical, psychological, and neuromodulation intervention in reducing pain in CPSP patients (PROSPERO Registration: CRD42022371835). Secondary outcomes included mood, sleep, global impression of change, and physical responses. Data extraction included participant demographics, stroke aetiology, pain characteristics, pain reduction scores, and secondary outcome metrics. Forty two original studies were included with a total of 1451 participants. No studies providing psychological therapy to CPSP patients were identified. Twelve studies met requirements for a random-effects meta-analyses that found: pharmacological therapy to have a small effect on mean pain score (SMD = -0.36, 96.0% Confidence Interval [-0.68, -0.03], physical interventions did not show a significant effect (SMD = -0.55, [-1.28, 0.18]), and neuromodulation treatments had a moderate effect (SMD -0.64, [-1.08, -0.19]). Fourteen studies were included in proportional meta-analysis with pharmacological studies having a moderate effect (58.3% mean pain reduction, [-36.51, -80.15]), and neuromodulation studies a small effect (31.1% mean pain reduction, [-43.45, -18.76]). Sixteen studies were included in the narrative review, findings from which largely supported meta-analyses results. Duloxetine, Amitriptyline and repetitive Transcranial Magnetic Stimulation (rTMS) had the most robust evidence for their effectiveness in alleviating CPSP induced pain. Further multi-centre placebo-controlled research is needed to ascertain the effectiveness of physical therapies, such as acupuncture and virtual reality, and invasive and non-invasive neuromodulation treatments. PERSPECTIVE: This article presents a top-down and bottom-up overview of evidence for the effectiveness of different pharmacological, physical, and neuromodulation treatments of CPSP. This review could provide clinicians with a comprehensive understanding of the effectiveness and tolerability of different treatment types.

6 May 2024 in Clinical Neurophysiology
Verified
Journal Article
Open access
BSBárbara Silva-Passadouro
Bárbara Silva-Passadouro
ATArnas Tamasauskas
Arnas Tamasauskas
OKOmar Khoja
Omar Khoja
ACAlexander Casson
Alexander Casson
Ioannis DelisIoannis Delis
Ioannis Delis
MSManoj Sivan
Manoj Sivan
Fibromyalgia Syndrome (FMS), Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID (LC) are similar multisymptom clinical syndromes but with difference in dominant symptoms in each individual. There is existing and emerging literature on possible functional alterations of the central nervous system in these conditions. This review aims to synthesise and appraise the literature on resting-state quantitative EEG (qEEG) in FMS, ME/CFS and LC, drawing on previous research on FMS and ME/CFS to help understand neuropathophysiology of the new condition LC. A systematic search of MEDLINE, Embase, CINHAL, PsycINFO and Web of Science databases for articles published between December 1994 and September 2023 was performed. Out of the initial 2510 studies identified, 17 articles were retrieved that met all the predetermined selection criteria, particularly of assessing qEEG changes in one of the three conditions compared to healthy controls. All studies scored moderate to high quality on the Newcastle-Ottawa scale. There was a general trend for decreased low-frequency EEG band activity (delta, theta, and alpha) and increased high-frequency EEG beta activity in FMS, differing to that found in ME/CFS. The limited LC studies included in this review focused mainly on cognitive impairments and showed mixed findings not consistent with patterns observed in FMS and ME/CFS. Our findings suggest different patterns of qEEG brainwave activity in FMS and ME/CFS. Further research is required to explore whether there are phenotypes within LC that have EEG signatures similar to FMS or ME/CFS. This could inform identification of reliable diagnostic markers and possible targets for neuromodulation therapies tailored to each clinical syndrome.

6 November 2023 in medRxiv
Verified
Preprint
Open access
PDF file
BSBárbara Silva-Passadouro
Bárbara Silva-Passadouro
ATArnas Tamasauskas
Arnas Tamasauskas
OKOmar Khoja
Omar Khoja
ACAlexander Casson
Alexander Casson
Ioannis DelisIoannis Delis
Ioannis Delis
MSManoj Sivan
Manoj Sivan
Long COVID (LC) is a multisymptom clinical syndrome with similarities to Fibromyalgia Syndrome (FMS) and Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). All these conditions are believed to be associated with centrally driven mechanisms such as central sensitisation. There is a lack of consensus on quantitative EEG (qEEG) changes observed in these conditions. This review aims to synthesise and appraise the literature on resting-state qEEG in LC, FMS and CFS/ME, to help uncover possible mechanisms of central sensitisation in these similar clinical syndromes. A systematic search of MEDLINE, Embase, CINHAL, PsycINFO and Web of Science databases for articles published between December 1994 and September 2023 was performed. Following screening for predetermined selection criteria and out of the initial 2510 studies identified, 17 articles were retrieved that met all the inclusion criteria, particularly of assessing qEEG changes in one of the three conditions compared to healthy controls. All studies scored moderate to high quality on the Newcastle-Ottawa scale. There was a general trend for decreased low-frequency EEG band activity (delta, theta, and alpha) and increased high-frequency EEG beta activity in FMS, whereas an opposite trend was found in CFS/ME. The limited LC studies included in this review focused mainly on cognitive impairments and showed mixed findings not consistent with patterns seen in FMS and CFS/ME. Further research is required to explore whether there are phenotypes within LC that have EEG signatures similar to FMS or CFS/ME. This could inform identification of reliable diagnostic markers and possible targets for neuromodulation therapies.

16 January 2024 in medRxiv
Verified
Preprint
Open access
PDF file
ATArnas Tamasauskas
Arnas Tamasauskas
AMAndrew Marshall
Andrew Marshall
BSBarbara Silva-Passadouro
Barbara Silva-Passadouro
NFNichollas Fallon
Nichollas Fallon
BFBernhard Frank
Bernhard Frank
SKSimon Keller
Simon Keller
Central post stroke pain (CPSP) is a neuropathic pain condition prevalent in 8% to 35% of stroke patients. This systematic review and meta-analysis aimed to provide insight in the effectiveness of available pharmacological, physical, psychological, and neuromodulation intervention in reducing pain in CPSP patients. Secondary outcomes included mood, sleep, global impression of change, and physical responses. Data extraction included participant demographics, stroke aetiology, pain characteristics, pain reduction scores, and secondary outcome metrics. Forty two original studies were included with a total of 1451 participants. Twelve studies met requirements for a random-effects meta-analysis which found: neuromodulation to be the most effective with a moderate effect on pain scores (SMD = -0.60, 95% confidence interval [-0.97, -0.23]), followed by physical interventions with moderate effect (SMD = -0.55, [-1.28, 0.18), and pharmacological interventions with a small effect on pain (SMD = -0.36, [-0.68, -0.03]). Fourteen studies were included in proportional meta-analysis with pharmacological studies having a moderate effect (58.34% mean reduction, [36.50, 80.18]), and neuromodulation studies a small effect (31.70% mean reduction, [21.44, 41.96]). Sixteen studies were included in the narrative review. While the overall medium risk of bias limits generalisation of findings, fluvoxamine and repetitive transcranial magnetic stimulation was found to have consistently good pain alleviation and relatively low risk of side effects. Anticonvulsants were found to have a significant effect on pain reduction, but were found to have the most side effects. Virtual reality and acupuncture show promising results, but lack rigorous methodological investigation to understand their full effect.

15 July 2025 in bioRxiv
Verified
Preprint
Open access
ATArnas Tamasauskas
Arnas Tamasauskas
IPIrene Perini
Irene Perini
JMJan Minde
Jan Minde
SKSimon S. Keller
Simon S. Keller
NFNicholas Fallon
Nicholas Fallon
AMAndrew Marshall
Andrew Marshall
Congenital insensitivity to pain (CIP) due to the R221W mutation on the nerve growth factor gene results in reduced peripheral C-nociceptor density and behavioural indifference to painful stimuli. While functional neuroimaging has revealed altered cortical and sub-cortical pain processing in R221W carriers, structural white matter changes remain unexplored and may suggest an anatomical basis of symptoms. Heterozygous R221W carriers’ (n = 11) and age-, sex-, education-matched controls’ (n = 11) diffusion tensor imaging data were compared using fixel-based analysis, and complimentary edge and node analyses using graph theory, and network-based statistics. Whole-brain and region of interest (ROI) fixel-based analyses revealed significantly reduced fibre density and fibre-bundle cross-section in brainstem motor tracts of R221W carriers, encompassing the corticospinal pathways, corona radiata, external capsule, cerebellar peduncles, and pontine crossing (p < 0.05). Graph theory analysis of pain-processing ROIs demonstrated reduced local efficiency in right anterior cingulate cortex (ACC) and altered betweenness centrality in bilateral insula and left ACC of R221W carriers. Despite R221W carriers showing higher node degrees in the somatosensory cortex and ACC, these connections had reduced efficiency and integration with cortical network regions. Network-based statistics identified a possible compensatory subnetwork with stronger connectivity from right thalamus to left ACC and left insula in R221W carriers (p < 0.019). These findings suggest that congenitally reduced peripheral nociception could lead to abnormalities in the thalamocortical and motor efferent pathway, but not sensory afferent pathways. The combination of reduced brainstem motor tract integrity and altered cortical network efficiency, alongside potentially compensatory thalamo-cortical connectivity, could support a model of R221W CIP as motor under-reactivity rather than sensory insensitivity.

19 April 2026 in PsyArXiv
Verified
Preprint
Open access
ATArnas Tamasauskas
Arnas Tamasauskas
AGAnusha Ghosal
Anusha Ghosal
ZBZachary Bowden-Thornley
Zachary Bowden-Thornley
BFBernhard Frank
Bernhard Frank
SKSimon Keller
Simon Keller
AMAndrew G. Marshall
Andrew G. Marshall
ObjectiveFibromyalgia is a chronic primary pain condition characterised by widespread pain, sleep disturbance, fatigue and cognitive impairment. The diagnostic criteria, aetiology, and legitimacy of symptoms remains contested, leading to poor patient experiences and perceived stigma. This review aimed to synthesise experiences of adults living with fibromyalgia in the United Kingdom, and outline areas of patient care improvement in the National Health Service.MethodsA qualitative evidence synthesis was conducted following PRISMA and ENTREQ guidance. Five electronic databases were systematically searched. Data extraction and quality appraisal using the Critical Appraisal Skills Programme were undertaken independently by two reviewers. Data were analysed using inductive thematic synthesis.ResultsN = 28 studies were included in the thematic synthesis and led to four themes: (1) The constant labour of productivity and self-management in an unreliable body, (2) navigating complex and changing relationships while managing internal turmoil, (3) finding legitimacy and agency within healthcare and welfare systems, and (4) mourning the past, making sense of the present, and negotiating an uncertain future. Combined, these themes show that receiving a diagnosis required persistent work against medical dismissal, but even when diagnosed, their pain was rarely effectively management amid disjointed care. The stigma against the diagnosis was both internal for patients, and perceived from external social, healthcare, and welfare systems.ConclusionsThese findings highlight the need for pain services that provide psychotherapy and education around fibromyalgia, improved integration of specialised pain care with local healthcare services, and wider training of healthcare clinicians in fibromyalgia diagnosis.